Loading...
Keywords
Last Name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by William Truog and Alain Cuna.

 
Connection Strength
 
 
 
3.467
 
  1. Cuna A, Quiqley A, Varghese K, Ciccolari-Micaldi G, Oliveros C, Cheng AL, Norberg M, Truog WE. Effectiveness and safety of repeat dexamethasone for bronchopulmonary dysplasia. J Perinatol. 2021 08; 41(8):1956-1962.
    View in: PubMed
    Score: 0.887
  2. Cuna A, Lewis T, Dai H, Nyp M, Truog WE. Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes. Pediatr Pulmonol. 2019 02; 54(2):165-170.
    View in: PubMed
    Score: 0.746
  3. Cuna A, Liu C, Govindarajan S, Queen M, Dai H, Truog WE. Usefulness of an Online Risk Estimator for Bronchopulmonary Dysplasia in Predicting Corticosteroid Treatment in Infants Born Preterm. J Pediatr. 2018 06; 197:23-28.e2.
    View in: PubMed
    Score: 0.709
  4. Cuna A, Lewis T, Oschman A, Dai HY, Brophy K, Norberg M, Nyp M, Truog W. Outcomes of Infants Who Failed to Extubate despite Systemic Corticosteroids. Am J Perinatol. 2017 12; 34(14):1458-1463.
    View in: PubMed
    Score: 0.677
  5. Cuna A, Lagatta JM, Savani RC, Vyas-Read S, Engle WA, Rose RS, DiGeronimo R, Logan JW, Mikhael M, Natarajan G, Truog WE, Kielt M, Murthy K, Zaniletti I, Lewis TR. Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants. Pediatr Pulmonol. 2021 10; 56(10):3283-3292.
    View in: PubMed
    Score: 0.225
  6. Mikhael M, Cleary JP, Zaniletti I, Truog WE, Ibrahim J, DiGeronimo R, Cuna A, Kielt MJ, Coghill CH, Vyas-Read S, Yallapragada S, Engle WA, Savani RC, Murthy K, Lagatta JM. Chronic lung disease in full-term infants: Characteristics and neonatal intensive care outcomes in infants referred to children's hospitals. Pediatr Pulmonol. 2022 09; 57(9):2082-2091.
    View in: PubMed
    Score: 0.059
  7. Feldman K, Nitkin CR, Cuna A, Oschman A, Truog WE, Norberg M, Nyp M, Taylor JB, Lewis T. Corticosteroid response predicts bronchopulmonary dysplasia status at 36 weeks in preterm infants treated with dexamethasone: A pilot study. Pediatr Pulmonol. 2022 07; 57(7):1760-1769.
    View in: PubMed
    Score: 0.059
  8. Vyas-Read S, Logan JW, Cuna AC, Machry J, Leeman KT, Rose RS, Mikhael M, Wymore E, Ibrahim JW, DiGeronimo RJ, Yallapragada S, Haberman BE, Padula MA, Porta NF, Murthy K, Nelin LD, Coghill CH, Zaniletti I, Savani RC, Truog W, Engle WA, Lagatta JM. A comparison of newer classifications of bronchopulmonary dysplasia: findings from the Children's Hospitals Neonatal Consortium Severe BPD Group. J Perinatol. 2022 01; 42(1):58-64.
    View in: PubMed
    Score: 0.056
  9. Linafelter A, Cuna A, Liu C, Quigley A, Truog WE, Sampath V, Oschman A. Extended course of prednisolone in infants with severe bronchopulmonary dysplasia. Early Hum Dev. 2019 09; 136:1-6.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.